AVEO PHARMACEUTICALS INC·4

Aug 21, 5:31 PM ET

Needle Michael N 4

4 · AVEO PHARMACEUTICALS INC · Filed Aug 21, 2017

Insider Transaction Report

Form 4
Period: 2017-08-17
Needle Michael N
Chief Medical Officer
Transactions
  • Other

    Common Stock Warrants (right to buy)

    2017-08-1725,90725,906 total
    Exercise: $1.00Exp: 2021-05-17Common Stock (25,907 underlying)
  • Other

    Stock Option (right-to-buy)

    2017-08-17205,729500,000 total
    Exercise: $1.07Exp: 2025-02-03Common Stock (205,729 underlying)
  • Other

    Common Stock

    2017-08-1725,90725,906 total
  • Other

    Stock Option (right to buy)

    2017-08-1767,889184,000 total
    Exercise: $1.08Exp: 2026-01-07Common Stock (67,889 underlying)
Footnotes (6)
  • [F1]On August 17, 2017, Michael Needle entered into a marital settlement agreement with his wife pursuant to which he agreed to transfer to his wife 50% of his common stock and warrants.
  • [F2]The warrants are immediately exercisable.
  • [F3]Under the marital settlement agreement, Dr. Needle is deemed to hold 205,729 of these options for the benefit of his wife, who is entitled to the shares issued upon exercise of such options by Dr. Needle. Dr. Needle's wife may be deemed an indirect beneficial owner of these options.
  • [F4]This option vested as to 25% of the shares on January 9, 2016 and vests in thirty-six equal monthly installments thereafter as to the remaining shares through January 9, 2019, subject to Dr. Needle's continued service to the Company.
  • [F5]Under the marital settlement agreement, Dr. Needle is deemed to hold 67,889 of these options for the benefit of his wife, who is entitled to the shares issued upon exercise of such options by Dr. Needle. Dr. Needle's wife may be deemed an indirect beneficial owner of these options.
  • [F6]The shares underlying this option vest in equal monthly installments from January 7, 2016, through January 7, 2020, subject to Dr. Needle's continued service to the Company.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION